Mar Riveiro-Barciela

Universitat Autònoma de Barcelona (UAB)

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Susana Guix

Associate Professor

University of Barcelona

SPAIN

View details

Celia Perales

SPAIN

View details

Agusti Bosch

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Álvaro Díaz‐González

SPAIN

View details

JOSEP QUER

Vall d'Hebron Institut de Recerca

SPAIN

View details

Rosa M Pintó

Professor

University of Barcelona

SPAIN

View details

Maria Isabel Costafreda Salvany

University of Barcelona

SPAIN

View details

Esteban Domingo

Research Professor

SPAIN

View details

Albert Bosch

University of Barcelona

SPAIN

View details

Nely Díaz Mejía

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mar Riveiro-Barciela

Research Interests

Explore related searches

Contact this professor

Articles (16)

Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis :

In-Host Flat-like Quasispecies :

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury

Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain

Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study

Specific Plasma MicroRNA Signatures Underlying the Clinical Outcomes of Hepatitis E Virus Infection

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments

Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient

Expert Clinical Management of Severe Immune-Related Adverse Events: Results from a Multicenter Survey on Hot Topics for Management

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?

Collaborators (10)

Susana Guix

Celia Perales

Agusti Bosch

Álvaro Díaz‐González

JOSEP QUER

Rosa M Pintó

Maria Isabel Costafreda Salvany

Esteban Domingo

Albert Bosch

Nely Díaz Mejía

Make your next move.